"Background.Noncirrhotic portal hypertension (NCPH) is a newly described life‐threatening liver disease of unknown cause in human immunodeficiency virus (HIV)–infected persons. Postulated pathogenesis includes prolonged exposure to antiretroviral therapy, particularly didanosine. ...
"Conclusions.We found a strong association between prolonged exposure to didanosine and the development of NCPH."
Read more in Clinical Infectious Diseases, July 9, 2009.
0 comments:
Post a Comment